The University of Leeds is one of the largest, research intensive universities in the UK, and a member of the prestigious Russell Group.

The breadth and depth of their research was recently recognised in the Research Excellence Framework (REF), which identified that 90% of University of Leeds research has a quality rating of “world-leading” or "internationally excellent”. The assessment measures the quality of outputs - including publications, performances, and exhibitions – and their impact on the economy, public policy, civil society or culture, along with the environment that supports research.

Through a truly interdisciplinary approach their community of researchers brings together excellence and innovation, pushing the frontiers of knowledge and discovery to address challenges including climate change, political and economic instability, inequality, poverty, and refugee crises that threaten the health and wellbeing of the population.

Parkinson Building

Health research excellence at Leeds 

  • The Leeds CRUK Clinical Trial Unit performs groundbreaking work to identify better and less toxic treatments for patients with blood cancers and treatments involving radiotherapy. 
  • Scientists in the Astbury Centre for Structural Molecular Biology use structural and imaging approaches to understand the molecular and cellular basis of cancer and to discover new routes towards future therapies and diagnostics. 
  • Researchers in the STORM laboratory are developing a new generation of intelligent robotic endoscopic instruments to enable earlier diagnosis, wider use of screening and more effective treatment for cancer.  
  • Leeds is a Tessa Jowell Centre of Excellence for brain cancer research and care.